About Bacchus Vascular
Bacchus Vascular is a company based in Santa Clara (United States) founded in 1999 was acquired by Covidien in March 2009. Bacchus Vascular has raised $31.5 million across 2 funding rounds from investors including Warburg Pincus, Covidien and Kaiser Permanente Ventures. Bacchus Vascular operates in a competitive market with competitors including Tactile Medical, Intervene, enVVeno Medical, Sky Medical Technology and DeVoro Medical, among others.
- Headquarter Santa Clara, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$31.5 M (USD)
in 2 rounds
-
Latest Funding Round
$6.5 M (USD), Series E
Apr 17, 2007
-
Investors
Warburg Pincus
& 3 more
-
Employee Count
Not available
-
Acquired by
Covidien
(Mar 01, 2009)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Bacchus Vascular
Bacchus Vascular has successfully raised a total of $31.5M across 2 strategic funding rounds. The most recent funding activity was a Series E round of $6.5 million completed in April 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bacchus Vascular
Bacchus Vascular has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Warburg Pincus, Covidien and Kaiser Permanente Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Locked | Locked | Locked | |
|
Tech and Life Sciences focused corporate VC firm investing in the US
|
Locked | Locked | Locked | |
|
Investments in early and late-stage US companies are made.
|
Locked | Locked | Locked |
Investor details for Bacchus Vascular
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bacchus Vascular
Investment portfolio details for Bacchus Vascular
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bacchus Vascular
Detailed financials for Bacchus Vascular
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bacchus Vascular Comparisons
Peer comparison for Bacchus Vascular
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bacchus Vascular
Bacchus Vascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tactile Medical, Intervene, enVVeno Medical, Sky Medical Technology and DeVoro Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Home therapy devices for lymphedema and venous ulcers are provided.
|
|
| Locked | Locked | Locked |
Catheter-based therapy for chronic venous insufficiency is developed.
|
|
| Locked | Locked | Locked |
Developer of medical device for the the treatment of venous diseases
|
|
| Locked | Locked | Locked |
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
|
|
| Locked | Locked | Locked |
Medical devices for treating cardiac diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of a device for CLI and PAD patients to prevent amputation
|
Detailed competitors of Bacchus Vascular
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bacchus Vascular
Complete news archive for Bacchus Vascular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bacchus Vascular
Bacchus Vascular was founded in 1999 and raised its 1st funding round 4 years after it was founded.
Bacchus Vascular is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Bacchus Vascular is a funded company, having raised a total of $31.5M across 2 funding rounds to date.
Bacchus Vascular was focused on medical devices for the treatment of occlusive vascular disease for interventional radiologists and vascular surgeons in the United States. Its product, the TRELLIS-8 Peripheral Infusion System is an isolated thrombolysis catheter that enables treatment of deep vein thrombosis and arterial occlusions by targeted delivery of clot-dissolving drugs. The company was founded in 1999 and is based in Santa Clara, California. It was acquired by Covidien in 2009 which in turn was acquired by Medtronic in 2015.
Bacchus Vascular's top competitors include Tactile Medical, Intervene and enVVeno Medical.
Bacchus Vascular has 4 investors. Key investors include Warburg Pincus, Covidien, Kaiser Permanente Ventures, and The Vertical Group.